focus -WSS

focus

author：knowledge 2025-09-30 12:10:30 - browse：52132

A crowd of miniature figurines facing towards an hourglass. -- cancer coverage from STAT — Adobe

It’s no secret that a lucky few seem to glide into old age, the years settling gracefully on their bodies, while others appear to have been dragged through time tied to a metaphorical garbage truck. Biologists have been developing numerous ways to measure the rate an individual ages — often called an accelerated or decelerated “biological age” — and trying to translate it into a heightened or reduced risk of the morbidity and mortality that comes with aging.

There’s been a proliferation of various biological aging clocks, mathematical models that look at things like genetic markers or proteins in your body to make some estimation of an individual’s biological age. Research interest in using these clocks has exploded. In the last five years, thousands of papers on or incorporating the clocks have been published. The paper describing one popular biological aging clock, PhenoAge, has over 1,800 citations alone. One recent study suggested that a reason cancer incidence is increasing among younger adults may be accelerated aging, based on this particular clock.

But as scientists use these clocks to associate biological age with specific health risks, like cancer or dementia, and numerous companies eagerly offer biological age measurements in exchange for hundreds of bucks, it may be worth noting that experts don’t agree on what “biological age” actually is.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Jerome Adams on the need for new antivirals for Covid
Next article： Rep. Raul Ruiz on the physician shortage and more

hotspot

WSS

Disappointing trial forces Pfizer to pivot on obesity medicine plans

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

The EPA's new lead rule: How one expert crunched the numbers

Pediatric cancer treatments threatened by a new FDA policy

UnitedHealth’s Optum accused of antitrust violations in California

Will the market for weight loss drugs really reach $100 billion?

explore

focus

This article is exclusive to STAT+ subscribers

Unlock this article — plus in-depth analysis, newsletters, premium events, and networking platform access.

entertainment

Walensky prepares to leave CDC — and Congress — behind

There's an unseen cost to disruptive road

23andMe had bad news about my health. I wish a person had delivered it

Rep. Raul Ruiz on the physician shortage and more

Drug repurposing or repositioning? The language matters

ReNAgade cuts staff seven months after raising $300 million

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Mayo Clinic plans $5B tech

In Memoriam: Notable people who died in 2023

With clinical trial data readouts, here's how to spot spin

knowledge

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Future doctors need a strong humanities education

30 years of 'Listening to Prozac'

Dana Farber says 6 studies to be retracted and 31 corrected

Pumping milk in bathrooms at health conferences is common

Will the market for weight loss drugs really reach $100 billion?

hotspot

focus

Wikipedia

leisure time